BIOS Capital Management, LP Q3 2025 Filing

Filed November 12, 2025

Portfolio Value

$88.9B

Holdings

6

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
ACTUACTUATE THERAPEUTICS INC
10,049,996$67.2B75.62%
2
CGTXCOGNITION THERAPEUTICS INC
6,000,000$8.1B9.11%
3
IRDOPUS GENETICS INC
3,683,429$6.6B7.42%
4
LTRNLANTERN PHARMA INC
1,015,715$4.4B4.97%
5
RNTXREIN THERAPEUTICS INC
1,690,751$1.9B2.19%
6
INABEURIN8BIO INC
286,664$622.1M0.70%